A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects
Clinical trial NCT03486236 · COMPLETED
Trial details
- NCT number
- NCT03486236
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-20
- Primary completion
- 2016-09-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.